Currently, albumin-based drugs include Abraxane (Celgene) (paclitaxel loaded albumin NP), optison (GE Healthcare, Chicago, Illinois, United States) (human serum albumin stabilized perflutren microspheres as an ultrasound contrast agent) and albumin-bound anti-cancer drugs (ABI-009 (Aadi with Celgene)—albumin-bound rapamycin and ABI-011 (NantBioScience, Los Angeles, California, United States)—albumin-bound thiocolchicine analog (IDN 5405)) [9]. Here, ALB is linked to cancer.